Position in PTCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,265,884
-$2,553,188 QoQ
Shares Held
136,003
-12.6% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. PTCT ranks #33 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in PTCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,265,884 | 136,003 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,819,072 | 155,596 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,478,241 | 121,855 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,120,726 | 125,322 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,223,478 | 141,748 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,038,061 | 133,763 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,002,422 | 107,882 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,403,557 | 78,599 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $41,758,113 | 1,435,480 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $684,378 | 30,539 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,107,438 | 51,818 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,571,490 | 32,442 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,876,605 | 75,363 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,811,117 | 95,839 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,339,584 | 58,402 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,338,645 | 35,879 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $537,744 | 13,501 | Shares | Sole | 2022-02-08 | |
| 2021-03-31 | $2,639,289 | 55,740 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $2,308,935 | 49,389 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,949,617 | 58,132 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,057,457 | 46,121 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||